Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome

Bone Marrow Transplantation

Volumn 39, Issue 3, 2007, Pages 143-147

  Sauer, M ^a   Zeidler, C ^a   Meissner, B ^a   Rehe, K ^a   Hanke, A ^a   Welte, K ^a   Lohse, P ^b   Sykora, K W ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEFIBROTIDE; DIURETIC AGENT; ETANERCEPT; FLUDARABINE; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; THYMOCYTE ANTIBODY; TREOSULFAN;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CHILD; CHIMERA; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG RESPONSE; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; HLA TYPING; HUMAN; HUMAN TISSUE; LUNG HEMORRHAGE; MALE; PILOT STUDY; PLEURA EFFUSION; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; SHWACHMAN SYNDROME; UNSPECIFIED SIDE EFFECT; VEIN OCCLUSION;

ABNORMALITIES, MULTIPLE; ADOLESCENT; BONE MARROW DISEASES; BUSULFAN; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MELPHALAN; PILOT PROJECTS; SYNDROME; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VIDARABINE;

EID: 33846639705     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705553     Document Type: Article

References (31)

1. Shwachman H, Diamond LK, Oski FA, Khaw KT. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr 1964; 65: 645-663.
2. Smith OP, Hann IM, Chessells JM, Reeves BR, Milla P. Haematological abnormalities in Shwachman-Diamond syndrome. Br J Haematol 1996; 94: 279-284.
3. Boocock GR, Morrison JA, Popovic M, Richards N, Ellis L, Durie PR et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 2003; 33: 97-101.
4. Rothbaum R, Perrault J, Vlachos A, Cipolli M, Alter BP, Burroughs S et al. Shwachman-Diamond syndrome: Report from an international conference. J Pediatr 2002; 141: 266-270.
5. Ginzberg H, Shin J, Ellis L, Morrison J, Ip W, Dror Y et al. Shwachman syndrome: Phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr 1999; 135: 81-88.
6. Lesesve JF, Dugue F, Gregoire MJ, Witz F, Dror Y. Shwachman-Diamond syndrome with late-onset neutropenia and fatal acute myeloid leukaemia without maturation: A case report. Eur J Haematol 2003; 71: 393-395.
7. Donadieu J, Michel G, Merlin E, Bordigoni P, Monteux B, Beaupain B et al. Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: Experience of the French neutropenia registry. Bone Marrow Transplant 2005; 36: 787-792.
8. Fleitz J, Rumelhart S, Goldman F, Ambruso D, Sokol RJ, Pacini D et al. Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman-Diamond syndrome. Bone Marrow Transplant 2002; 29: 75-79.
9. Slattery JT, Kalhorn TF, McDonald GB, Lambert K, Buckner CD, Bensinger WI et al. Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients. J Clin Oncol 1996; 14: 1484-1494.
10. Savilahti E, Rapola J. Frequent myocardial lesions in Shwachman's syndrome. Eight fatal cases among 16 Finnish patients. Acta Paediatr Scand 1984; 73: 642-651.
11. Browne RK, Scheltinga DM, Pomering M, Mahony M. Testicular myxosporidiasis in anurans, with a description of Myxobolus fallax n.sp. Syst Parasitol 2002; 52: 97-110.
12. Voorter CE, Rozemuller EH, de Bruyn-Geraets D, van der Zwan AW, Tilanus MG, van den Berg-Loonen EM. Comparison of DRB sequence-based typing using different strategies. Tissue Antigens 1997; 49: 471-476.
13. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729-735.
14. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
15. Vibhakar R, Radhi M, Rumelhart S, Tatman D, Goldman F. Successful unrelated umbilical cord blood transplantation in children with Shwachman-Diamond syndrome. Bone Marrow Transplant 2005; 36: 855-861.
16. Stary J, Locatelli F, Niemeyer CM. Stem cell transplantation for aplastic anemia and myelodysplastic syndrome. Bone Marrow Transplant 2005; 35 (Suppl 1): S13-S16.
17. Tsai PH, Sahdev I, Herry A, Lipton JM. Fatal cyclophosphamide-induced congestive heart failure in a 10-year-old boy with Shwachman-Diamond syndrome and severe bone marrow failure treated with allogeneic bone marrow transplantation. Am J Pediatr Hematol Oncol 1990; 12: 472-476.
18. Sensenbrenner LL, Owens Jr AH, Heiby JR, Jeejeebhoy HF. Comparative effects of cytotoxic agents on transplanted hematopoietic and antibody-producing cells. J Natl Cancer Inst 1973; 50: 1027-1033.
19. Fried W, Kedo A, Barone J. Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma. Cancer Res 1977; 37: 1205-1209.
20. Thomas ED, Buckner CD, Rudolph RH, Fefer A, Storb R, Neiman PE et al. Allogeneic marrow grafting for hematologic malignancy using HL-A matched donor-recipient sibling pairs. Blood 1971; 38: 267-287.
21. Keating MJ, O'Brien S, Lerner S, Koller C, Beran M, Robertson LE et al. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood 1998; 92: 1165-1171.
22. Chun HG, Leyland-Jones B, Cheson BD. Fludarabine phosphate: A synthetic purine antimetabolite with significant activity against lymphoid malignancies. J Clin Oncol 1991; 9: 175-188.
23. McDonald GB, Slattery JT, Bouvier ME, Ren S, Batchelder AL, Kalhorn TF et al. Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood 2003; 101: 2043-2048.
24. Kashyap A, Wingard J, Cagnoni P, Roy J, Tarantolo S, Hu W et al. Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality. Biol Blood Marrow Transplant 2002; 8: 493-500.
25. Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983; 309: 1347-1353.
26. Bearman SI. Veno-occlusive disease of the liver. Curr Opin Oncol 2000; 12: 103-109.
27. Scheulen ME, Hilger RA, Oberhoff C, Casper J, Freund M, Josten KM et al. Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies. Clin Cancer Res 2000; 6: 4209-4216.
28. van Pel M, van Breugel DW, Vos W, Ploemacher RE, Boog CJ. Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers. Bone Marrow Transplant 2003; 32: 15-22.
29. Fichtner I, Becker M, Baumgart J. Antileukaemic activity of treosulfan in xenografted human acute lymphoblastic leukaemias (ALL). Eur J Cancer 2003; 39: 801-807.
30. Locatelli F, Pession A, Comoli P, Bonetti F, Giorgiani G, Zecca. M et al. Role of allogeneic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemia. Br J Haematol 1996; 92: 49-54.
31. Locatelli F, Niemeyer C, Angelucci E, Bender-Gotze C, Burdach S, Ebell W et al. Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: A report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol 1997; 15: 566-573.